Literature DB >> 18779454

Inhibition of lipoprotein-associated phospholipase activity by darapladib: shifting gears in cardiovascular drug development: are antiinflammatory drugs the next frontier?

S Matthijs Boekholdt, Robbert J de Winter, John J P Kastelein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18779454     DOI： 10.1161/CIRCULATIONAHA.108.795195

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  2 in total

Review 1.  Inflammation in atherosclerosis: from pathophysiology to practice.

Authors:  Peter Libby; Paul M Ridker; Göran K Hansson
Journal:  J Am Coll Cardiol       Date:  2009-12-01       Impact factor: 24.094

2.  Monitoring inflammation injuries in the progression of atherosclerosis with contrast enhanced ultrasound molecular imaging.

Authors:  Ruiying Sun; Jie Tian; Jun Zhang; Liping Wang; Jing Guo; Yani Liu
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.